Today

Agents

Chat

Arena

Discover

More

App

Exagen Inc. Q2 Revenue USD 19.941 Million Vs. IBES Estimate USD 17.8 Million - XGN News | Rallies

Exagen Inc. Q2 Revenue USD 19.941 Million Vs. IBES Estimate USD 17.8 Million

XGN•2026-08-04

Q2 results and outlook

Aug. 4 (Reuters) - Exagen Inc. Q2 net income was USD -3.196 million.

Q2 operating expenses were USD 13.939 million.
FY revenue outlook is USD 72–75 million vs. IBES estimate of USD 71.6 million.

Related News

Standard Motor Products Q2 FY26 diluted EPS rises 18.8% to $1.39; net sales increase 1.6% to $501.6 million

SMP•2026-08-04

Schwab survey shows U.S. stock market bullish sentiment jumps to 47% in Q3 2026

SCHW•2026-08-04

Evolus expands Symatese partnership to commercialize Estyme HA gels in Canada, Australia, New Zealand

EOLS•2026-08-04

Host Hotels publishes 2026 corporate responsibility report outlining sustainability, resilience progress

HST•2026-08-04

Wave Life Sciences CEO to speak at BofA Securities SMID Cap Executive Insights event

WVE•2026-08-04